We approach every study with a mindset focused on solving clients’ challenges with tailored solutions and expertise specific to our Neurological diseases focus areas:
Neurodegeneration  |  Seizures  |   Sleep  |   Neuromuscular  |   Pain  |   Hearing loss
Prof. dr. Leonard van den Berg, neurologist at University Medical Centre (UMC) Utrecht and ALS Centrum. He is experienced in conducting global ALS trials, established the prominent TRICALS site network, and is chair of the European Network for the Cure of ALS.
Prof. dr. Anne Schilder, Ear Institute at University College London (UCL) senior investigator and leader of NIHR UCLH Biomedical Research Centre’s programme for translational hearing. She is a world leader in ENT research.
Prof. dr. Eugen Trinka, chair of the neurology department at Paracelsus Medical University Salzburg and the Austrian Society of Neurology’s president-elect.
Professor John Harrison, Chief Scientific Officer at Scottish Brain Sciences, is a renowned cognition expert with 25 years of experience in aiding over 80 CNS drug development organizations. His contributions include developing the Neuropsychological Test Battery for Alzheimer’s studies and playing a pivotal role in Brintellix’s development and registration. As an Associate Professor at AUmc Alzheimer Center and Visiting Professor at King’s College London, he holds Chartered Psychologist status and has authored over 100 books and scientific articles.
Dr. Cris Lanting, clinical physicist-audiologist, as well as a paediatric audiologist at Radboud University Medical Center (UMC).
Dr. Jort Vijverberg, a neurologist at the Brain Research Center and a senior researcher at Alzheimercentrum Amsterdam. He has been the principal investigator on many Alzheimer’s clinical trials and consults with the pharmaceutical industry.
Professor of Cognitive Health at Oxford University, the Director of Dementias Platform UK, and the Director of the BrainWaves Study of Adolescent Wellbeing and Mental Health. An expert on brain health and the use of big data in medical research, Professor Gallacher holds a visiting professorship at Imperial College London and an honorary professorship at the University of Hong Kong. He is the Principal Investigator for the Caerphilly Prospective Study (CaPS).
Renowned researcher in Neurodegenerative diseases, particularly dementia. His work focuses on understanding vascular contributions to dementia and developing novel therapies. With over two decades of experience, Prof. Hainsworth has published extensively and presented his findings internationally, contributing significantly to the field.
Professor Dag Aarsland is a renowned expert in neurodegenerative diseases, specializing in dementia and Parkinson’s disease. He holds a professorship in Old Age Psychiatry at King’s College London and leads the Centre for Age-Related Medicine at Stavanger University Hospital in Norway. As chair in the European Dementia with Lewy Bodies Consortium (E-DLB), he advances crucial research in this field. With numerous publications and research grants, Professor Aarsland is dedicated to improving diagnosis, treatment, and care for patients with cognitive impairments.
Dr. Marieke Niesters is an experienced anesthesiologist and pain specialist at Leiden University Medical Center. With a focus on innovative approaches to pain management, her work integrates cutting-edge research and clinical practice to improve patient outcomes. Dr. Niesters is dedicated to advancing the understanding and treatment of chronic pain, contributing to both academic research and patient care.
Brain Clinical is our proprietary network for Neurological diseases trials, providing experienced investigators and sites for Neurological diseases clinical trials.
We leverage our unique triangle of Science, Networks, and Operational excellence to run efficient trials across our Neurological diseases areas of expertise. A prime example is the SAPHIR study.
In the SAPHIR study, we helped the Sponsor fine-tune their protocol and identify specialised sites to overcome recruitment challenges. We ultimately helped them find 120 patients at 24 sites and streamline their project’s path to completion.
On NOVEMBER 26th, 2024, we organised the webinar: Time to event trial designs in ALS: How useful are they? During this webinar, our speakers Ruben van Eijk, Lotte Smets, Jordi van Unnik and host Lieza Exalto explored the following topics:A...
On the 27th of June, we organized the webinar: 'Clinical Consequences of the New MASLD Nomenclature' with guest speaker Prof. Maja Thiele.During this webinar, our speaker and hosts dived into the following topics:Is the MASLD nomeclature...
On October 15, at 16.00 CEST, we presented the webinar:Plasma biomarkers for diagnosis and monitoring of neurodegenerative disordersTopics that are discussed:Plasma biomarkers, such as Amyloid, pTau and NfL. Treatment effect in ne...
Explore our Neurlogical diseases capabilities, case studies, and other resources.
"*" indicates required fields
"*" indicates required fields
